InnoCare Pharma Limited
INCPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,817 | -$48,059 | $17,968 | -$165,223 |
| Dep. & Amort. | $0 | $58,998 | $0 | $107,126 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $32,039 | $0 | -$10,792 |
| Change in WC | $0 | -$88,288 | $0 | -$15,687 |
| Other Non-Cash | $4,703 | -$73,031 | $38,557 | $52,161 |
| Operating Cash Flow | -$114 | -$118,341 | $56,524 | -$32,416 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,947 | -$9,873 | -$15,058 | -$6,961 |
| Net Acquisitions | $0 | $1 | $0 | $0 |
| Inv. Purchases | -$545,141 | -$466,743 | $0 | $0 |
| Inv. Sales/Matur. | $490,175 | $460,635 | $0 | $0 |
| Other Inv. Act. | $0 | $54 | $93,281 | -$240,851 |
| Investing Cash Flow | -$56,913 | -$15,927 | $78,223 | -$247,812 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $17,419 | -$19,976 | -$31,721 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $820 | -$813 | $0 | -$13,354 |
| Dividends Paid | $0 | -$8,423 | -$8,175 | -$8,317 |
| Other Fin. Act. | -$2,767 | $24,789 | $72,650 | -$2,230 |
| Financing Cash Flow | $15,471 | -$4,423 | $32,754 | -$23,902 |
| Forex Effect | $25,110 | -$4,231 | -$3,258 | $33,958 |
| Net Chg. in Cash | -$16,446 | -$142,921 | $164,244 | -$270,171 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $973,975 | $4,843,710 | $4,679,466 | $4,949,637 |
| End Cash | $957,529 | $4,700,789 | $4,843,710 | $4,679,466 |
| Free Cash Flow | -$2,061 | -$128,214 | $41,466 | -$39,377 |